Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 5-ALA Photodynamic Detection in Oral Lichen Planus
2006-004760-31Phase 3Terminated
- Sponsor
- University of Dundee
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of 5-aminolevulinic acid in oral lichen planus (OLP) and mouth cancer, sponsored by University of Dundee. Primary endpoints: Diagnostic discrimination via PpIX fluorescence and Lesion border delineation. Started Mar 2009; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
oral lichen planus (OLP)mouth cancer
Beyond the preview
Go deeper on 2006-004760-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004760-31.